About
Kevin is a Venture Partner with Catapult’s GM&C Life Sciences Fund, where he assesses investment opportunities and works with the Fund’s smaller investments to help companies successfully grow, with a particular focus on medical devices. Kevin has held a number of non-executive and Chairman positions, including Monica Healthcare, which generated a 3.5x cash return for Catapult, and Crystallon, which generated a 5.2x cash return. He is also a Director and former Chairman of both Surface Transforms plc (AIM listed) and Hallmarq Veterinary Imaging Ltd. Kevin was a founding director of Ferraris Group plc (FTSE: listed) and created Salusinvest in 2006 to invest in a number of EU and US life science businesses. He is also a former Director of Acuity VCT 3 and Octopus VCT 1. Kevin graduated from Leeds University with a BSc in Chemical Engineering and has an MBA from Manchester Business School.
Position in the VCSift Database
- • 8 investors at Catapult Ventures are tracked.
- • 421 investors hold the Venture Partner role in VCSift. Kevin D'Silva is one of them.
- • 8,972 investors are based in London, England, United Kingdom.
Data sourced from 410,343 investor profiles. Updated June 2026.
Investment Focus
- Location
- London, UK
Contact Information
Find more investors like Kevin
Search Investors